ANI PHARMACEUTICALS INC reports

Company location: Princeton, NJ
Fiscal year end: 31 December

ANI PHARMACEUTICALS INC has filed 1,754 SEC EDGAR filings since 23 Dec 1999

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 526-550 of 1,000 matching filings.

Per page

25

Current page

22

4

4 filing

Filing date: 12 Apr 2022
Reporting date: 10 Apr 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 08 Apr 2022
Reporting date: 06 Apr 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 08 Apr 2022
Reporting date: 06 Apr 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 30 Mar 2022
Reporting date: 28 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 30 Mar 2022
Reporting date: 28 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 28 Mar 2022
Reporting date: 24 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 28 Mar 2022
Reporting date: 24 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 28 Mar 2022
Reporting date: 24 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 28 Mar 2022
Reporting date: 24 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 28 Mar 2022
Reporting date: 24 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 25 Mar 2022
Reporting date: 23 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 25 Mar 2022
Reporting date: 23 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 25 Mar 2022
Reporting date: 23 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

DEF 14A File 001-31812

DEF 14A

Filing date: 25 Mar 2022
Reporting date: 27 Apr 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 23 Mar 2022
Reporting date: 21 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-31812

FORM 8-K

Filing date: 23 Mar 2022
Reporting date: 19 Mar 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

4 filing

Filing date: 22 Mar 2022
Reporting date: 21 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 22 Mar 2022
Reporting date: 18 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 22 Mar 2022
Reporting date: 19 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

3

3 filing

Filing date: 22 Mar 2022
Reporting date: 19 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 21 Mar 2022
Reporting date: 17 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

10-K File 001-31812

10-K

Filing date: 15 Mar 2022
Reporting date: 31 Dec 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-31812

FORM 8-K

Filing date: 15 Mar 2022
Reporting date: 15 Mar 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

SC 13D File 005-60689

SC 13D

Filing date: 02 Mar 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-31812

FORM 8-K

Filing date: 28 Feb 2022
Reporting date: 23 Feb 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .